The FDA Isn't Just Approving Nicotine Pouch Flavors — It's Approving Big Tobacco's Next Business Model

Rich Berry. Cappuccino, in 2 and 4 milligram strengths. Autumn Spice. Those read like a coffee shop’s fall menu, not a federal drug-review docket — but they’re the names the FDA cleared for sale on August 4 and 5, authorizing four new “on!” nicotine pouch products from Helix Innovations for the national market.

I don’t think this process is protecting anyone. I think the FDA’s flavor-by-flavor authorization pipeline has become the tobacco industry’s fastest route to market for exactly the products most likely to hook a teenager, and the agency is calling that paperwork science.

Here’s what’s actually happening, stripped of the acronyms. Every new tobacco product needs “marketing authorization” — FDA sign-off that a company can legally sell it — granted through a Premarket Tobacco Product Application, or PMTA, a review of the health data a manufacturer submits. In September 2025, the FDA launched what it calls the Tobacco Review Pilot Program: essentially a fast lane for nicotine pouch applications, built so agency staff work directly with manufacturers as a file moves instead of reviewing it cold. That pilot has now cleared 30 pouch products for sale — 20 Zyn, 10 “on!” — on top of roughly 45 separately authorized vape products. None of that speed is accidental. It’s the system working as designed.

FDA Center for Tobacco Products Acting Director Bret Koplow has framed authorizations like this one as consumer protection, saying the goal is to give adult users “clear, science-based information about the relative harms of tobacco products, so they can make informed choices.” Heart and lung health groups aren’t buying it, and they’ve objected publicly on youth-uptake grounds. The case for why is concrete, not theoretical: a local television investigation in Jackson, Tennessee found the state has no license requirement for tobacco retailers at all, even as Jackson alone has more than 20 vape shops and CDC data shows 1.63 million U.S. students already reporting e-cigarette use. “These products are highly addictive,” Caroline Joyce of Parents Against Vaping told the station, “and incredibly discreet” — a pouch sits under the lip with no cloud, no smell, no device to confiscate.

The industry isn’t hiding what pouches are for. British American Tobacco’s own CEO has called pouches “an engine of growth” with “the potential to replace cigarettes in the long run,” and the balance sheet backs him up: pouch volumes across Asia, the Middle East, and Africa jumped 27.5% in the first half of this year alone, and BAT is projecting a $15 billion pouch market with 47 million users by 2030. Philip Morris’s U.S. pouch line already generates eight times the profit per thousand units of its international cigarette business. That math only pencils out if the flavor list keeps expanding and the user base keeps growing younger — and a fifteen-year-old with an Autumn Spice pouch tucked under her lip in third period isn’t a rounding error against that plan. She’s the plan.

Anyone navigating nicotine or tobacco use in their own life or a kid’s deserves better than a regulator processing candy flavors on a conveyor belt and calling it caution. The honest read of this month’s authorizations isn’t that the system slipped somewhere. It’s that the system is moving exactly as fast as the industry needs it to.